Cardiogenic Shock Supported With VA-ECMO: Association Between cDPP3 Concentrations and Outcomes in a Post Hoc Analysis of the ADRECMO Cohort

This publication has 16 references indexed in Scilit:

• Cardiogenic Shock
  New England Journal of Medicine, 2026
• High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial
  Journal of Cardiac Failure, 2024
• Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
  New England Journal of Medicine, 2023
• Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes
  European Heart Journal, 2023
• Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial
  Circulation, 2023
• Criteria for Defining Stages of Cardiogenic Shock Severity
  JACC, 2022
• High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort
  British Journal of Anaesthesia, 2022
• Circulating Dipeptidyl Peptidase 3 and Alteration in Haemodynamics in Cardiogenic Shock: Results from the OptimaCC Trial
  European Journal of Heart Failure, 2019
• Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves Haemodynamics
  European Journal of Heart Failure, 2019
• Angiotensin II for the Treatment of Vasodilatory Shock
  New England Journal of Medicine, 2017